Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hacker

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Journal of Virology|November 4, 2020
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence StudiesCraig Fenwick, Antony Croxatto, Alix T Coste, et al.
Cell|August 25, 2015
Population Variation and Genetic Control of Modular Chromatin Architecture in HumansSebastian M Waszak, Olivier Delaneau, Andreas R Gschwind, et al.
Vaccines|April 30, 2021
A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold ResponseDuško Lainšček, Tina Fink, Vida Forstnerič, et al.
Science (New York, N.Y.)|October 19, 2013
Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcriptionHelena Kilpinen, Sebastian M Waszak, Andreas R Gschwind, et al.
Iscience|January 9, 2023
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan regionMarc Emmenegger, Elena De Cecco, David Lamparter, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Journal of Virology|November 4, 2020
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence StudiesCraig Fenwick, Antony Croxatto, Alix T Coste, et al.
Cell|August 25, 2015
Population Variation and Genetic Control of Modular Chromatin Architecture in HumansSebastian M Waszak, Olivier Delaneau, Andreas R Gschwind, et al.
Vaccines|April 30, 2021
A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold ResponseDuško Lainšček, Tina Fink, Vida Forstnerič, et al.
Science (New York, N.Y.)|October 19, 2013
Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcriptionHelena Kilpinen, Sebastian M Waszak, Andreas R Gschwind, et al.
Iscience|January 9, 2023
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan regionMarc Emmenegger, Elena De Cecco, David Lamparter, et al.
Pageof 6